Factors that affect accuracy of α-fetoprotein test in detection of hepatocellular carcinoma in patients with cirrhosis.
about
Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysisSurveillance for Hepatocellular Carcinoma in Patients with NASHAn assessment of benefits and harms of hepatocellular carcinoma surveillance in patients with cirrhosis.Correlation analysis of peripheral blood T cell subgroups, immunoglobulin and prognosis of early hepatocellular carcinoma after hepatectomy.Decrypting cryptogenic hepatocellular carcinoma: clinical manifestations, prognostic factors and long-term survival by propensity score model.Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice.Optimizing Surveillance Performance of Alpha-Fetoprotein by Selection of Proper Target Population in Chronic Hepatitis B.Development and Internal Validation of a Model for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis.Survival Analysis of Hepatocellular Carcinoma: A Comparison Between Young Patients and Aged Patients.The Doylestown Algorithm: A Test to Improve the Performance of AFP in the Detection of Hepatocellular CarcinomaLiver Transplantation for Hepatocellular Carcinoma beyond Milan Criteria: Multidisciplinary Approach to Improve Outcome.The changing landscape of hepatocellular carcinoma: etiology, genetics, and therapyImproved Detection of Hepatocellular Carcinoma by Using a Longitudinal Alpha-Fetoprotein Screening Algorithm.Improved Performance of Serum Alpha-Fetoprotein for Hepatocellular Carcinoma Diagnosis in HCV Cirrhosis with Normal Alanine Transaminase.The Asia-Pacific Working Party on Nonalcoholic Fatty Liver Disease Guidelines 2017 Part 1: Definition, risk factors and assessment.Cirrhosis Patients with Nonalcoholic Steatohepatitis Are Significantly Less Likely to Receive Surveillance for Hepatocellular Carcinoma.Diagnostic delays are common among patients with hepatocellular carcinoma.Hepatocellular Carcinoma Surveillance Among Patients With Cirrhosis in a Population-based Integrated Health Care Delivery System.Predictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosis.Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatment and outcome.Extrahepatic metastasis risk of hepatocellular carcinoma based on α-fetoprotein and tumor staging parameters at cross-sectional imaging.Changes in the Glycosylation of Kininogen and the Development of a Kininogen-Based Algorithm for the Early Detection of HCC.Impact of etiology of chronic liver disease on hepatocellular carcinoma biomarkers.Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis.Should AFP (or any biomarkers) be used for HCC surveillance?Plasma mSEPT9: A Novel Circulating Cell-free DNA-Based Epigenetic Biomarker to Diagnose Hepatocellular Carcinoma.Potential of alpha-fetoprotein as a prognostic marker after curative radiofrequency ablation of hepatocellular carcinoma.Application of the Doylestown algorithm for the early detection of hepatocellular carcinoma
P2860
Q21144594-B81D4ACC-D80B-497B-A20D-0FC13BF11E24Q26747428-679569FB-368A-4B60-9533-7D319BBC0797Q33436257-D619E161-EB1B-4DE3-A794-A0FDD3297DFEQ34769963-225BD7B7-C016-42FB-9459-1CD7AFA21535Q35107166-DD9B69DD-8C8D-4111-8020-EDF405F915C9Q36199751-38112441-CBC7-4154-8404-B858B2A24C28Q36229496-3D6F0DA9-40F4-4389-8998-A0CE5F4BEDBEQ36404471-514C5542-8B81-4628-9876-FDFF0BBEBF33Q36523063-E20D840B-C827-4BB1-B4C8-36553C82B41BQ36540674-063CBDD1-20C9-46D7-B101-1022779EB0AFQ36962089-C00BBF6B-7B7A-476F-813A-A6B9F0576F9AQ37606028-C21DD957-2AA4-40C1-9657-E324B98A9477Q38279464-93050435-9A5D-4477-BC76-8272078DB5B1Q38930591-DFF7204F-3968-4FFB-BB99-61DC47166392Q39410610-3EA5A226-76A3-45C5-8126-8957F75B2F3FQ40214331-E0FD3F3C-10AD-4741-A286-7F0BFD965089Q40279432-2075A67E-0F27-4C0D-A6A1-81F6A76499B0Q40442376-EB0A8E9F-CDB5-4D7F-BE27-8860699E35D5Q40468745-21976AC4-23C5-410A-9A40-DE2495D20C2DQ41054698-355B5714-04AA-4E98-96C3-53DCB729DCFDQ42649817-2845B3D0-F56D-4648-AC6B-884DB1FEF8CDQ46512130-B416400E-79F0-413A-A4EB-25C0F98AB83BQ47253648-9EE55DBE-C101-4D0B-B02C-7C6EDB542A48Q50095994-45074AA3-1B1A-4EEF-B941-B32BFC5CB16AQ50223186-7CECED16-BB07-41AF-8E16-E9981902DFEAQ52600964-55B13832-1820-430A-9381-6E5075A3C5A2Q53209421-59FD29B3-7ABE-45ED-9A5C-E773CF0BF624Q58782471-04D37A4A-84BB-4766-8722-5C5F27C899E9
P2860
Factors that affect accuracy of α-fetoprotein test in detection of hepatocellular carcinoma in patients with cirrhosis.
description
2013 թվականի հոկտեմբերի 2-ին հրատարակված գիտական հոդված
@hy
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
name
Factors that affect accuracy o ...... ma in patients with cirrhosis.
@en
Factors that affect accuracy o ...... ma in patients with cirrhosis.
@nl
type
label
Factors that affect accuracy o ...... ma in patients with cirrhosis.
@en
Factors that affect accuracy o ...... ma in patients with cirrhosis.
@nl
prefLabel
Factors that affect accuracy o ...... ma in patients with cirrhosis.
@en
Factors that affect accuracy o ...... ma in patients with cirrhosis.
@nl
P2093
P2860
P1476
Factors that affect accuracy o ...... ma in patients with cirrhosis.
@en
P2093
Adam C Yopp
Akbar K Waljee
Amit G Singal
Jason Chiang
Mahendra Nehra
Pragathi Kandunoori
Purva Gopal
P2860
P304
P356
10.1016/J.CGH.2013.09.053
P407
P577
2013-10-02T00:00:00Z